Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Tamaki Hirata"'
Autor:
Ryota, Ito, Hiroki, Tatsuoka, Tamaki, Hirata, Sachiko, Kimura, Youichi, Sakamoto, Takao, Kashiwagi, Junko, Hori, Keikichi, Miyata, Minoru, Kishi, Masahide, Iwai
Publikováno v:
Gan to kagaku ryoho. Cancerchemotherapy. 48(10)
The patient was a 69-year-old man diagnosed with stage ⅣB lung adenocarcinoma with 95% programmed death- ligand 1 expression, and pembrolizumab monotherapy was initiated. The patient exhibited fatigue from the 12th course(36 weeks after treatment i
Autor:
Yasuhisa Shinomura, Tamaki Hirata, Hiroyuki Yamamoto, Shina Horiuchi, Mariko Oki, Kohzoh Imai, Yasushi Adachi, Hiroaki Taniguchi
Publikováno v:
The Journal of Pathology. 211:516-523
Gastric cancers with and without high-frequency microsatellite instability (MSI-H) represent distinctive pathways of carcinogenesis. The aim of this study was to clarify if human leukocyte antigen (HLA) class I antigen subunits and antigen processing
Autor:
Tamaki HIRATA, Yoshiyasu KARINO, Tomohiro ARAKAWA, Yasuaki KUWATA, Jun AKAIKE, Katsu YAMAZAKI, Takahiro SATO, Takumi OMURA, Joji TOYOTA
Publikováno v:
Kanzo. 45:8-13
Autor:
Minoru Kishi, Takuma Suzuki, Satoshi Kusaka, Naoki Yoshioka, Tamaki Hirata, Hirohei Yamamura, Takao Mitsuhashi, Masahide Iwai, Takao Kashiwagi, Tadahiro Inagaki
Publikováno v:
Nihon Naika Gakkai Zasshi. 101:2045-2047
Autor:
Kentaro, Minagawa, Hiroki, Kawano, Takuma, Suzuki, Tadahiro, Inagaki, Minoru, Kishi, Tamaki, Hirata, Sachiko, Kimura, Miho, Takechi, Toru, Koide, Masahide, Iwai, Yoshio, Katayama, Toshimitsu, Matsui
Publikováno v:
[Rinsho ketsueki] The Japanese journal of clinical hematology. 54(5)
Lenalidomide treatment for refractory or relapsed multiple myeloma in elderly patients may be feasible in an outpatient setting. However, difficulties have been associated with the management of adverse effects. Therefore, a dose reduction in lenalid
Autor:
Takao, Kashiwagi, Tadahiro, Inagaki, Minoru, Kishi, Satoshi, Kusaka, Takuma, Suzuki, Tamaki, Hirata, Masahide, Iwai, Naoki, Yoshioka, Takao, Mitsuhashi, Hirohei, Yamamura
Publikováno v:
Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine. 101(7)
Autor:
Kentaro Minagawa, Sachiko Kimura, Yoshihiro Nakagawa, Miho Takechi, Yoshio Katayama, Takuma Suzuki, Noriko Miwa, Tadahiro Inagaki, Sayaka Kashiwagi, Hiroki Kawano, Masahide Iwai, Makoto Koide, Satoshi Kusaka, Toshimitsu Matsui, Minoru Kishi, Takao Kashiwagi, Tamaki Hirata
Publikováno v:
Annals of Hematology. 93:1609-1610
Dear Editor, HIVor HHV-8-related primary effusion lymphoma (PEL) is a rare and poor prognostic disease which presents as serous effusion without detectable tumor masses. PEL occasionally has both immunoglobulin (Ig) and T cell receptor (TCR) gene rea
Autor:
Tamaki, Hirata, Hiroyuki, Okuda, Kentaro, Kawakami, Yasutaka, Suga, Tomohiro, Kato, Kazuya, Suzuki, Susumu, Nishimura, Yuichi, Kimura, Kazuhiko, Yonezawa, Takashi, Abe, Hideyuki, Ikeda, Yasuhisa, Shinomura
Publikováno v:
Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology. 106(6)
A 47-year-old woman patient who presented with weakness in the proximal parts of the upper and lower limbs and difficulty in swallowing was given a diagnosis of advanced esophageal cancer complicated with polymyositis. Steroid therapy was initiated f
Autor:
Mariko Oki, Kohzoh Imai, Hiroaki Taniguchi, Yasuhisa Shinomura, T. Endo, Katsuhiko Nosho, Yasushi Adachi, Tamaki Hirata, Hiroyuki Yamamoto, Nobuki Miyamoto
Publikováno v:
Oncogene. 24(53)
Aberrant activation and upregulation of the Wnt pathway is a key feature of many cancers. Wnt antagonists have recently attracted wide attention. Wnt inhibitory factor-1 (WIF-1) is a secreted antagonist that can bind to Wnt proteins directly and inhi
Autor:
Hiroyuki Yamamoto, Nobuki Miyamoto, Kohzoh Imai, Akravit Vinitketkumnuen, Hiroaki Taniguchi, Arisa Imsumran, Katsuhiko Nosho, Tamaki Hirata, Yasushi Adachi, Masahiro Fujita, Yuji Hinoda, Masao Hosokawa
Publikováno v:
Carcinogenesis. 25(12)
Expression of matrilysin-2, matrix metalloproteinase (MMP)-26, has been implicated in the progression of several types of human cancer. Matrilysin-2 has been reported to be a physiological and pathological activator of pro-MMP-9. The aim of this stud